Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robert Janknegt, Adrianne Faber, Rob Rodrigues Pereira & Luuk J Kalverdijk. (2009) InforMatrix for attention deficit hyperactivity disorder. Expert Opinion on Pharmacotherapy 10:5, pages 755-772.
Read now
Read now
Articles from other publishers (15)
XiTing Lian, Qing Xu, YuLing Wang, LeYuan Gu, Qian Yu, WeiHui Shao, HaiXiang Ma, Yue Shen, Lu Liu, JiaXuan Gu & HongHai Zhang. (2023) Noradrenergic pathway from the locus coeruleus to heart is implicated in modulating SUDEP. iScience 26:4, pages 106284.
Crossref
Crossref
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu & Feng Chen. (2023) Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. European Journal of Clinical Pharmacology.
Crossref
Crossref
Di Fu, Dan-Dan Wu, Hong-Li Guo, Ya-Hui Hu, Ying Xia, Xing Ji, Wei-Rong Fang, Yun-Man Li, Jing Xu, Feng Chen & Qian-Qi Liu. (2022) The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Frontiers in Psychiatry 12.
Crossref
Crossref
T.D. Vloet & B. Herpertz-Dahlmann. 2019. Therapie-Handbuch. Therapie-Handbuch
564
572
.
T.D. Vloet & B. Herpertz-Dahlmann. 2018. Therapie-Handbuch. Therapie-Handbuch
811
818
.
Tomoya Yukawa, Ikuo Fujimori, Taku Kamei, Yoshihisa Nakada, Nobuki Sakauchi, Masami Yamada, Yusuke Ohba, Hiroyuki Ueno, Maiko Takiguchi, Masako Kuno, Izumi Kamo, Hideyuki Nakagawa, Yasushi Fujioka, Tomoko Igari, Yuji Ishichi & Tetsuya Tsukamoto. (2016) Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2. Bioorganic & Medicinal Chemistry 24:14, pages 3207-3217.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
111
143
.
David J. O’Neill, Adedayo Adedoyin, Jenifer A. Bray, Darlene C. Deecher, Andrew Fensome, Joel A. Goldberg, Jim Harrison, Liza Leventhal, Charles Mann, Lilly Mark, Lisa Nogle, Nicole R. Sullivan, Taylor B. Spangler, Eugene A. Terefenko, Eugene J. Trybulski, Albert J. Uveges, An Vu, Garth T. Whiteside & Puwen Zhang. (2011) Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152). Journal of Medicinal Chemistry 54:19, pages 6824-6831.
Crossref
Crossref
David J. O’Neill, Adedayo Adedoyin, Peter D. Alfinito, Jenifer A. Bray, Scott Cosmi, Darlene C. Deecher, Andrew Fensome, Jim Harrison, Liza Leventhal, Charles Mann, Casey C. McComas, Nicole R. Sullivan, Taylor B. Spangler, Albert J. Uveges, Eugene J. Trybulski, Garth T. Whiteside & Puwen Zhang. (2010)
Discovery of Novel Selective Norepinephrine Reuptake Inhibitors: 4-[3-Aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3
H
)-yl]-1-(methylamino)butan-2-ols (WYE-103231)
. Journal of Medicinal Chemistry 53:11, pages 4511-4521.
Crossref
Crossref
Christien G.W. de JongSéverine Van De VoordeHerbert RoeyersRuth RaymaekersAlbert J. AllenSimone KnijffHelene VerhelstAlfons H. TemminkLeo M.E. SmitRob Rodriques-PereiraDirk VandenbergheInge van WelsenLiesbeth ter SchurenMazim Al-HakimAzad AminLaurens VlasveldJaap OosterlaanJoseph A. Sergeant. (2009) Differential Effects of Atomoxetine on Executive Functioning and Lexical Decision in Attention-Deficit/Hyperactivity Disorder and Reading Disorder. Journal of Child and Adolescent Psychopharmacology 19:6, pages 699-707.
Crossref
Crossref
Brigette S. Vaughan, Holly J. Roberts & Howard Needelman. (2009) Current medications for the treatment of Attention-Deficit/Hyperactivity Disorder. Psychology in the Schools 46:9, pages 846-856.
Crossref
Crossref
Alcy R. Torres, Jane Whitney & Joseph Gonzalez-Heydrich. (2008) Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: Review of pharmacological treatment. Epilepsy & Behavior 12:2, pages 217-233.
Crossref
Crossref
Suyash Prasad & Chris Steer. (2008) Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder. Pediatric Drugs 10:1, pages 39-47.
Crossref
Crossref
Atilla Turgay. (2006) Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder. Therapy 3:1, pages 19-38.
Crossref
Crossref
Jud Staller & Stephen V Faraone. (2006) Attention-Deficit Hyperactivity Disorder in Girls. CNS Drugs 20:2, pages 107-123.
Crossref
Crossref